Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Overleving oudere CML-patiënt blijft achter, ook in TKI-tijdperk
jul 2020 | Leukemie, Ouderen